Rapid Communication
Copyright ©2008 The WJG Press and Baishideng.
World J Gastroenterol. May 28, 2008; 14(20): 3224-3230
Published online May 28, 2008. doi: 10.3748/wjg.14.3224
Table 3 Association between clinical variables and survival in patients with cholangiocarcinoma
Variable (n)Median survival (mo)P (Univariate)
Age
< 50 (11)10.23 (1.87-18.6)0.410
≥ 50 (44)9.17 (3.9-14.4)
Gender
Male (33)9.17 (3.8-14.5)0.386
Female (22)9.9 (0.4-19.4)
Bilirubin
< 10 (27)9.9 (3.1-16.7)0.012
≥ 10 (17)2.87 (1.2-4.5)
BMI
< 25 (18)13.0 (8.5-17.6)0.412
25-30 (16)7.0 (3.2-10.8)
≥ 30 (18)4.0 (0.5-7.6)
Surgery
Yes (21)10.23 (4.82-15.64)0.038
No (34)8.7 (1.8-15.6)
Type of surgery
Whipple (6)16.6 (0.0-39.4)0.988
Hepatic lobectomy (6)10.2 (3.9-16.6)
Bile duct excision (9)14.3 (8.5-20.1)
Metastasis
Yes (19)7.07 (0.0-15.83)0.256
No (36)9.09 (6.05-13.75)
Stenting
Yes (24)9.9 (0.45-19.35)0.930
No (32)9.16 (4.6-13.7)
Chemotherapy
Yes (14)16.96 (11.5-22.4)0.038
No (41)6.2 (0-12.9)
Chemotherapy in unresected patients
Yes (8)17 (12.76-21.18)0.001
No (25)3.5 (1.12-5.8)